Research Article

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone

Table 1

D with add-back reduced endometriosis symptoms. Values are means (SEM); indicates a statistically significant difference relative to baseline values, .

Baseline
3 months
6 months

Number of days out of 28 with bleeding greater than spotting5.2 (0.3)0.8 (0.5)2.5 (1.4)
Overall pain rating, out of 2858.1 (8.2)17.5 (4.9)19.6 (5.6)
Pain rating on bleeding days23.6 (3.2) 
out of 52
0.0 (0.0)
out of 8
2.6 (1.3)
out of 25
Number of days out of 28 on which pain medication was used6.4 (1.0)0.7 (0.4)1.1 (0.5)
CPSSS total7.4 (0.4)2.5 (0.5)3.4 (0.7)
 NMPP1.6 (0.1)0.6 (0.1)0.8 (0.2)
 Dysmenorrhea2.1 (0.2)0.3 (0.1)0.5 (0.2)
 Dyspareunia1.2 (0.2)0.5 (0.2)0.8 (0.2)
 Pelvic tenderness1.5 (0.1)0.8 (0.2)0.9 (0.2)
 Pelvic induration1.2 (0.1)0.4 (0.1)0.6 (0.2)